NoTeaPartyPleez
Gold Member
- Dec 2, 2012
- 11,826
- 1,912
- 245
Ha! Remember this guy, the asshole who raised an HIV pill from $13 to $750? The rightwing capitalist, free market hero?
Company hikes price 5,000% for drug that fights complication of AIDS, cancer | US Message Board - Political Discussion Forum
Arrested this morning. You idiots who cheer Big Pharma and monopolies need your heads pulled out of your asses:
FBI arrests Turing Pharmaceuticals CEO Martin Shkreli: Witness
Turing Pharmaceuticals CEO Shkreli arrested by FBI
Martin Shkreli, a lightning rod for growing outrage over soaring prescription drug prices, was arrested by the FBI on Thursday after a federal investigation involving his former hedge fund and a pharmaceutical company he previously headed.
The securities fraud probe of Shkreli, who is now chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals, stems from his time as manager of hedge fund MSMB Capital Management and CEO of biopharmaceutical company Retrophin Inc, a person familiar with the matter said.
Lawyers for Retrophin and Shkreli, whose arrest was witnessed by Reuters, did not immediately respond to a request for comment. Turing and KaloBios declined to comment.
Turing sparked controversy earlier this year after news reports that it had raised the price of Daraprim, a 62-year-old treatment for a dangerous parasitic infection, to $750 a tablet from $13.50 after acquiring it.
Shkreli, 32, was expected to be charged on Thursday for illegally using Retrophin assets to pay off debts after MSMB lost millions of dollars, the source said.
Company hikes price 5,000% for drug that fights complication of AIDS, cancer | US Message Board - Political Discussion Forum
Arrested this morning. You idiots who cheer Big Pharma and monopolies need your heads pulled out of your asses:
FBI arrests Turing Pharmaceuticals CEO Martin Shkreli: Witness
Turing Pharmaceuticals CEO Shkreli arrested by FBI
Martin Shkreli, a lightning rod for growing outrage over soaring prescription drug prices, was arrested by the FBI on Thursday after a federal investigation involving his former hedge fund and a pharmaceutical company he previously headed.
The securities fraud probe of Shkreli, who is now chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals, stems from his time as manager of hedge fund MSMB Capital Management and CEO of biopharmaceutical company Retrophin Inc, a person familiar with the matter said.
Lawyers for Retrophin and Shkreli, whose arrest was witnessed by Reuters, did not immediately respond to a request for comment. Turing and KaloBios declined to comment.
Turing sparked controversy earlier this year after news reports that it had raised the price of Daraprim, a 62-year-old treatment for a dangerous parasitic infection, to $750 a tablet from $13.50 after acquiring it.
Shkreli, 32, was expected to be charged on Thursday for illegally using Retrophin assets to pay off debts after MSMB lost millions of dollars, the source said.